Who invested in Zhaoke Ophthalmology Pharmaceutical?
Zhaoke Ophthalmology Pharmaceutical's investors include OrbiMed and Hill House Capital.
One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$145Mraised across 1 round since 2020, from 1 source
Zhaoke Ophthalmology Pharmaceutical's investors include OrbiMed and Hill House Capital.
Zhaoke Ophthalmology Pharmaceutical has raised $145M across 1 round since 2020.
Zhaoke Ophthalmology Pharmaceutical's most recent round was a Series B of $145M in Oct 2020.
Its most recent round, $145M in Oct 2020, is also its largest on record.
Zhaoke Ophthalmology Pharmaceutical's first round on record, in Oct 2020, was backed by OrbiMed and Hill House Capital.
Zhaoke Ophthalmology Pharmaceutical's latest named round is a Series B, in Oct 2020.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.